Stay updated on Evobrutinib Study in RMS: evolutionRMS 1 Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib Study in RMS: evolutionRMS 1 Clinical Trial page.

Latest updates to the Evobrutinib Study in RMS: evolutionRMS 1 Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error, with the site revision updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check11 days agoChange DetectedAn NIH announcement banner was added with links to transition updates and a notice about the agency’s terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check18 days agoChange DetectedThe footer’s site revision number changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check46 days agoChange DetectedA 403 Forbidden error page now appears, replacing the expected study record content; the page shows an HTML skeleton and error message, indicating the study details are currently inaccessible and surrounding content has been removed.SummaryDifference17%

- Check67 days agoChange DetectedThe page now lists '2019 ( U.S. NIH Grant/Contract )' under funding sources, clarifying the U.S. NIH support for the study. The footer shows the site revision updated to v3.6.6, replacing v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Evobrutinib Study in RMS: evolutionRMS 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib Study in RMS: evolutionRMS 1 Clinical Trial page.